Demographic details of study patients
| Female sex | 6 | (46.1%) |
| Age (mean±SD) | 42.6 | (±13.0) |
| Disease duration | 15.4 | (±10.4) |
| Age at diagnosis (mean±SD) | 27.7 | (±13.1) |
| Diagnosis <16 years old (A1) | 2 | (15.4%) |
| Diagnosis 17–40 years old (A2) | 9 | (69.2%) |
| Diagnosis >40 years old (A3) | 2 | (15.4%) |
| Location | ||
| Ileal only (L1) | 1 | (7.7%) |
| Colonic only (L2) | 4 | (30.8%) |
| Ileo-colonic (L3) | 8 | (61.5%) |
| Concomitant upper GI disease (L4) | 2 | (15.4%) |
| Perianal disease (p) | 2 | (15.4%) |
| Behaviour | ||
| Inflammatory (B1) | 9 | (69.2%) |
| Stricturing (B2) | 2 | (15.4%) |
| Penetrating (B3) | 2 | (15.4%) |
| HBI (median, range) | 0 | (0–7) |
| Active disease HBI ≥5 | 4 | (30.8%) |
| Previous surgery | 8 | (61.5%) |
| Medications | ||
| Thiopurines | 7 | (53.8%) |
| Biologics | 4 | (30.8%) |
| Others | 3 | (23.1%) |
GI, gastrointestinal; HBI, Harvey Bradshaw Index.